<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="167">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 14, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04805892</url>
  </required_header>
  <id_info>
    <org_study_id>#Biozek-ARTC-US</org_study_id>
    <nct_id>NCT04805892</nct_id>
  </id_info>
  <brief_title>Open Label, Single-Center Study Utilizing BIOZEK COVID-19 Antigen Rapid Test as Compared to Standard Testing Technique. Test Performed by a Professional Versus Self-collection and Standard of Care</brief_title>
  <official_title>Open Label, Single-Center Study Utilizing BIOZEK COVID-19 Antigen Rapid Test as Compared to Standard Testing Technique. Test Performed by a Professional Versus Self-collection and Standard of Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mach-E B.V.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mach-E B.V.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a research study to evaluate the Sensitivity and Specificity of BIOZEK COVID-19&#xD;
      Antigen Rapid Test on samples collected by a healthcare professional versus self-collection;&#xD;
      and to perform analysis to compare results. In addition, to obtain RT-PCR test results,&#xD;
      performed prior to enrollment, and compare all three results.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 17, 2021</start_date>
  <completion_date type="Anticipated">May 17, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 27, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity and Specificity of BIOZEK COVID-19 Antigen Rapid Test on a sample collected by healthcare professionals.</measure>
    <time_frame>1 Month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity and Specificity of BIOZEK COVID-19 Antigen Rapid Test on self-collected sample.</measure>
    <time_frame>1 Month</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Covid19</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>BIOZEK COVID-19 Antigen Rapid Test</intervention_name>
    <description>The BIOZEK COVID-19 Antigen Rapid Test is used for the detection of SARS-CoV-2 antigens in nasopharyngeal swab specimens from individuals who are suspected of having COVID-19.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Subjects must be â‰¥18 years of age and have had an RT-PCR test performed prior to&#xD;
        enrollment.&#xD;
&#xD;
        Subjects must be able to understand and willingly sign a written informed consent.&#xD;
        Additionally, participants need to meet at least 1 of the criteria listed below:&#xD;
&#xD;
          -  Currently experiencing symptoms of COVID-19.&#xD;
&#xD;
          -  Be clinically diagnosed or suspected to have COVID-19.&#xD;
&#xD;
          -  Recent past (3 weeks) exhibited symptoms of COVID-19.&#xD;
&#xD;
          -  Be capable of performing a self-collection of a nasopharyngeal sample with use of&#xD;
             nasal swab kit.&#xD;
&#xD;
          -  Interacted with a COVID-19 positive individual.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Subjects who meet any of the following exclusion criteria may not be enrolled in this&#xD;
        study:&#xD;
&#xD;
          -  Cannot perform self-collection of a nasopharyngeal sample with use of nasal swab kit.&#xD;
&#xD;
          -  Have a deviated nasal septum.&#xD;
&#xD;
          -  Cognitively impaired individuals resulting in the inability to provide informed&#xD;
             consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Mobile Covid Services LLC</name>
      <address>
        <city>Flushing</city>
        <state>New York</state>
        <zip>11354</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela Khaitova</last_name>
      <phone>917-499-0737</phone>
      <email>mobilecovidservices@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Damian Stega, MD</last_name>
      <phone>9174990737</phone>
      <email>dstega@optonline.net</email>
    </contact_backup>
    <investigator>
      <last_name>Damian Stega, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Angela Khaitova</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 17, 2021</study_first_submitted>
  <study_first_submitted_qc>March 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 18, 2021</study_first_posted>
  <last_update_submitted>March 17, 2021</last_update_submitted>
  <last_update_submitted_qc>March 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

